Crossmark

Association between quantitative CT body composition analysis and prognosis in cetuximab-based first-line treatment for advanced colorectal cancer patients

Crossref DOI link: https://doi.org/10.1186/s12885-024-13338-8

Published Online: 2024-12-26

Update policy: https://doi.org/10.1007/springer_crossmark_policy

Authors

Dang, Wenxi

Wu, Shusheng

Liu, Xudong

Shen, Hao

Chen, Yaolin

Zhang, Zhihua

Wang, Haoyu

Cai, Zhirun

Li, Mengge

Sun, Mingjie

Gao, Fei

He, Yifu
License Information

Text and Data Mining valid from 2024-12-26

Version of Record valid from 2024-12-26
More Information

Article History

Received: 27 February 2024

Accepted: 12 December 2024

First Online: 26 December 2024

Declarations

:

: This study was approved by the Ethics Committee of Anhui Provincial Cancer Hospital of Anhui Medical University(Batch No:2024-ZNY-02). All subjects signed an informed consent form.

: The authors declare no competing interests.

Document is current

Any future updates will be listed below